中文

News & Events

dMed and GenScript signed strategic agreement
2020-04-20Return>>
dMed Biopharmaceutical (Shanghai) Co., Ltd., a global CRO based in China, and GenScript ProBio, CDMO business segment of GenScript Biotech Corporation, jointly announce that the parties will integrate their resource advantages in new drug clinical development and closely collaborate to advance biologics development in the whole industry chain from clinical development to commercial production services.

According to the collaboration agreement, dMed will offer high-quality services to GenScript's customers in terms of biologics IND filings in China, the US and Europe, clinical research, NDA, and pharmaceutical regulations. Through the strategic collaboration, the parties will integrate their advantages in professional management teams and technical platforms and offer adequate support to GenScript ProBio's regulatory affairs and clinical medicine affairs in ongoing or potential projects.

China:
298 Xiangke Road, 3/F, 301-305, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201210, China
Tel: +86 21 5090 0085 Fax: +86 21 6875 5515
US:
261 Madison Avenue, 24th fl. New York, NY 10016 US
Phone: +1-212-681-2100
沪ICP备16041651号 Copyright © 2016 dMed All Rights Reserved
沪公网安备 31011502005403号